Cocrystal Pharma Inc (COCP)

Cocrystal Pharma (COCP) Stock Price & Analysis


COCP Stock Chart & Stats

Day’s Range$0 - $0
52-Week Range$1.74 - $3.72
Previous Close$1.95
Average Volume (3M)31.47K
Market Cap
Enterprise ValueN/A
Total Cash (Recent Filing)$32.49M
Total Debt (Recent Filing)$176.00K
Price to Earnings (P/E)-0.2
Nov 13, 2023
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-10.00
Shares Outstanding10,173,790
10 Day Avg. Volume19,789
30 Day Avg. Volume31,473
Standard Deviation0.35
Financial Highlights & Ratios
Price to Book (P/B)0.62
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-1.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/Ebitda0.00
Price Target Upside464.10% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering2



Risk Analysis

Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy

Product Insights

Sorry, No Data Available
There is no website visitor data available for this stock.



What was Cocrystal Pharma Inc’s price range in the past 12 months?
Cocrystal Pharma Inc lowest stock price was $1.74 and its highest was $3.72 in the past 12 months.
    What is Cocrystal Pharma Inc’s market cap?
    Currently, no data Available
    When is Cocrystal Pharma Inc’s upcoming earnings report date?
    Cocrystal Pharma Inc’s upcoming earnings report date is Nov 13, 2023 which is in 45 days.
      How were Cocrystal Pharma Inc’s earnings last quarter?
      Cocrystal Pharma Inc released its earnings results on Aug 14, 2023. The company reported -$0.5 earnings per share for the quarter, beating the consensus estimate of -$0.58 by $0.08.
        Is Cocrystal Pharma Inc overvalued?
        According to Wall Street analysts Cocrystal Pharma Inc’s price is currently Undervalued. Get more investment ideas with TipRanks Premium
          Does Cocrystal Pharma Inc pay dividends?
          Cocrystal Pharma Inc does not currently pay dividends.
          What is Cocrystal Pharma Inc’s EPS estimate?
          Cocrystal Pharma Inc’s EPS estimate is -$0.53.
            How many shares outstanding does Cocrystal Pharma Inc have?
            Cocrystal Pharma Inc has 10,173,790 shares outstanding.
              What happened to Cocrystal Pharma Inc’s price movement after its last earnings report?
              Cocrystal Pharma Inc reported an EPS of -$0.5 in its last earnings report, beating expectations of -$0.58. Following the earnings report the stock price went up 4.152%.
                Which hedge fund is a major shareholder of Cocrystal Pharma Inc?
                Currently, no hedge funds are holding shares in COCP


                Cocrystal Pharma Stock Smart Score

                This stock does not have enough of the key information we need to rate it accurately. Smart Score is calculated for stocks traded in Nasdaq, NYSE, TSE and LSE with a market cap above $30M and average 3 months trading volume above $30K.
                Learn more about TipRanks Smart Score

                Company Description

                Cocrystal Pharma Inc

                Cocrystal Pharma, Inc. is a biotechnology company, which engages in the discovery and development of novel antiviral therapeutics. It focuses on the preclinical and early clinical stage antiviral compounds for unmet medical needs including influenza, Hepatitis C virus, and norovirus infections. The company was founded on January 2, 2014 and is headquartered in Bothell, WA.


                Top 5 ETFs holding COCP

                Market Value
                Smart Score
                Vanguard Total Stock Market ETF
                Up to five ETFs with an Outperform Smart Score that hold COCP. The ETFs are listed according to market value of COCP within the ETF

                Forecast EPS vs Actual EPS

                Similar Stocks
                Price & Change
                Aptose Biosciences
                Bio-Path Holdings

                Popular Stocks

                What's Included in PREMIUM?
                Make informed decisions based on Top Analysts' activity
                Know what industry insiders are buying
                Get actionable alerts from top Wall Street Analysts
                Find out before anyone else which stock is going to shoot up
                Get powerful stock screeners & detailed portfolio analysis